1. Azuma, K. 2015. Regulatory landscape of regenerative medicine in Japan. Current Stem Cell Reports 1(2): 118–128.
2. Berfield, S. 2013. Stem cell showdown: Celltex vs. the FDA. Businessweek, January 4.
http://www.businessweek.com/articles/2013-01-03/stem-cell-showdown-celltex-vs-dot-the-fda
.
3. Callaway, E. 2011. American scientist arrested in stem-cell clinic sting. Nature News Blog, December 29.
http://blogs.nature.com/news/2011/12/american-scientist-arrested-in-stem-cell-clinic-sting.html
. Accessed June 18, 2013.
4. Center for Biologics Evaluation and Research. 2011. Guidance for industry: Current good tissue practice (CGTP) and additional requirements for manufacturers of human cells, tissues, and cellular and tissue-based products (HCT/Ps).
http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/tissue/ucm285223.pdf
. Accessed October 7, 2015.
5. Chalmers, D. 2010. Stem cell technology: From research regulation to clinical applications. In Contested cells: Global perspectives on the stem cell debate, edited by B. Capps and A. Campbell, 63–94. London: Imperial College Press.